A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

Recruiting Observational Study
Breast Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,867 (estimated)
Sponsor
Spanish Breast Cancer Research Group · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is a prospective, multicenter non-interventional cohort study designed to develop a registry in unresectable locally advanced or metastatic disease.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients (males or females) diagnosed with unresectable locally advanced or MBC (either after a recurrence or as first diagnosis) from January 2016 onwards. 2. Patients who died are allowed to be included on the study. 3. Able and willing to provide written informed consent i…
Contacts

MS Study Project Manager

+34 916892870

inicio_ensayos@geicam.org

CONTACT

Start-Up Unit Manager

+34 916892870

inicio_ensayos@geicam.org

CONTACT